Top Markets
Coin of the day
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Rangering i aksjer #19936
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Aksjekurs
$5.22
Sist synkronisert: 2026-08-25
Markedsverdi
$146.14M
Endring (1 dag)
-1.35%
Endring (1 år)
-32.08%
Land
BE
Handel Hyloris Pharmaceuticals S.A. (HYL)

Kategori

Historikk for aksjesplitt for Hyloris Pharmaceuticals S.A. (HYL)
Aksjen Hyloris Pharmaceuticals S.A. (symbol: HYL) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 26, 2026.
Én HYL-aksje kjøpt før Aug 26, 2026 tilsvarer i dag 0 HYL-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH